As the U.S. and European ecosystems become more closely connected, exiting in the U.S. market is becoming a strategic consideration for many fast-growing companies. For some, establishing a presence in the U.S. market will also be a key inflection point. This panel provides an overview on how best to prepare for and complete a strategic exit in the United States via initial public offering (IPO) or acquisition. You will come away with practical business and legal tips from panellists with years of experience counselling high-growth companies in the U.S., Europe and worldwide.

Euronext lays out the strategic value of raising capital on the public stock market -- including the ability to accelerate growth, boost a company's profile with stakeholders and provide liquidity for investors wanting buy or sell shares -- and shows how Euronext's TechShare pre-IPO program can help biotech companies take the next step. Euronext is the right place for European companies that want to reinforce the European ecosystem but also aim to attract US investors. Including a Q&A session with Euronext executives.